BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2013
View Archived Issues
Serum IL-33 levels predict rheumatoid arthritis response to rituximab
Read More
MOD-6030 shows promise in animal models of obesity and type 2 diabetes
Read More
Uncovering new genetic and clinical biomarkers of human disease
Read More
Vaxart reports preclinical findings for new H7N9 avian influenza vaccine
Read More
ViroPharma provides update on phase II studies of maribavir
Read More
EntreMed files new drug global trial application for ENMD-2076 in China
Read More
Navidea Biopharmaceuticals begins phase III NAV-4694 trial
Read More
Boehringer Ingelheim synthesizes new GPR119 receptor agonists
Read More
AstraZeneca acquires Pearl Therapeutics
Read More
Verastem completes first stage of VS-6063 combination trial
Read More
FDA approves Exelon patch to treat all stages of Alzheimer's disease
Read More
Bisono Tape transdermal patch approved in Japan
Read More
Soliris receives FDA orphan drug designation for neuromyelitis optica
Read More
Drisapersen receives FDA breakthrough therapy designation
Read More
UGP-302 evaluated in animal models of obesity and diabetes
Read More
Amgen presents novel tankyrase inhibitor
Read More
Approval of Lemtrada for relapsing remitting MS recommended in Europe
Read More
Nexavar submitted in U.S and E.U. for radioactive iodine-refractory differentiated thyroid cancer
Read More
EMA recommends approval of two GSK cancer drugs
Read More
European CHMP recommends approval of two infliximab biosimilars
Read More
Takeda withdraws MAA for peginesatide in Europe
Read More
FDA issues complete response for Xarelto to reduce the risk of stent thrombosis in ACS
Read More
Regorafenib recommended for approval in the E.U.
Read More
CHMP issues positive opinion on two variations for Velcade
Read More
Autifony Therapeutics presents new potassium channel modulators
Read More
Merck & Co. receives FDA complete response letter for suvorexant
Read More
Cadila Healthcare synthesizes novel renin inhibitors
Read More
